An isolated polypeptide

Priyank Shukla

An isolated polypeptide

Research output: Patent

Abstract

The present invention relates to an isolated polypeptide that finds utility in generating an immune response against a virus in a subject. Also disclosed are immunogenic compositions comprising the isolated polypeptide, generating an immune response against a virus in a subject, and preventing or treating a viral infection in a subject, in particular a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Original language	English
Patent number	WO2022180163A1
IPC	A61K 39/12 2006.1,A61P 31/14 2006.1,C07K 14/005 2006.1,C07K 14/165 2006.1
Priority date	24/02/21
Filing date	24/02/22
Publication status	Published online - 1 Sept 2022

Keywords

SARS-CoV-2
Covid-19
Covid
Immunoinformatics
Bioinformatics
Peptide
Vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022180163

Cite this

@misc{b862123a0bfe4d359961c44d870e0d7e,

title = "An isolated polypeptide",

abstract = "The present invention relates to an isolated polypeptide that finds utility in generating an immune response against a virus in a subject. Also disclosed are immunogenic compositions comprising the isolated polypeptide, generating an immune response against a virus in a subject, and preventing or treating a viral infection in a subject, in particular a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.",

keywords = "SARS-CoV-2, Covid-19, Covid, Immunoinformatics, Bioinformatics, Peptide, Vaccine",

author = "Priyank Shukla",

year = "2022",

month = sep,

day = "1",

language = "English",

publisher = "World Intellectual Property Organisation",

address = "Switzerland",

type = "Patent",

note = "WO2022180163A1; A61K 39/12 2006.1,A61P 31/14 2006.1,C07K 14/005 2006.1,C07K 14/165 2006.1",

}

TY - PAT

T1 - An isolated polypeptide

AU - Shukla, Priyank

PY - 2022/9/1

Y1 - 2022/9/1

N2 - The present invention relates to an isolated polypeptide that finds utility in generating an immune response against a virus in a subject. Also disclosed are immunogenic compositions comprising the isolated polypeptide, generating an immune response against a virus in a subject, and preventing or treating a viral infection in a subject, in particular a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

AB - The present invention relates to an isolated polypeptide that finds utility in generating an immune response against a virus in a subject. Also disclosed are immunogenic compositions comprising the isolated polypeptide, generating an immune response against a virus in a subject, and preventing or treating a viral infection in a subject, in particular a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

KW - SARS-CoV-2

KW - Covid-19

KW - Covid

KW - Immunoinformatics

KW - Bioinformatics

KW - Peptide

KW - Vaccine

UR - https://patents.google.com/patent/WO2022180163A1/

M3 - Patent

M1 - WO2022180163A1

Y2 - 2022/02/24

PB - World Intellectual Property Organisation

ER -

An isolated polypeptide

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage

Cite this